TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
SGX: T14 (TJ DaRenTang USD)
Kemas kini terakhir: semalam, 1:05AM3.36
0.08 (2.44%)
| Penutupan Terdahulu | 3.28 |
| Buka | 3.27 |
| Jumlah Dagangan | 143,500 |
| Purata Dagangan (3B) | 202,959 |
| Modal Pasaran | 4,293,447,168 |
| Harga / Pendapatan (P/E TTM) | 5.01 |
| Harga / Jualan (P/S) | 3.20 |
| Harga / Buku (P/B) | 1.91 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Mar 2025 |
| Hasil Dividen (DY TTM) | 50.00% |
| Margin Keuntungan | 33.20% |
| Margin Operasi (TTM) | 27.05% |
| EPS Cair (TTM) | 0.400 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -30.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -3.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.96% |
| Nisbah Semasa (MRQ) | 2.00 |
| Aliran Tunai Operasi (OCF TTM) | 1.37 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.84 B |
| Pulangan Atas Aset (ROA TTM) | 4.79% |
| Pulangan Atas Ekuiti (ROE TTM) | 29.65% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (SG) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | TJ DaRenTang USD | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.88 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| TJ DARENTANG USD | 4 B | 50.00% | 5.01 | 1.91 |
| CMS | 5 B | 1.16% | 19.36 | 1.60 |
| IX BIOPHARMA | 203 M | - | - | 52.68 |
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Mid Value |
| % Dimiliki oleh Orang Dalam | 8.85% |
| % Dimiliki oleh Institusi | 0.15% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Tianjin Pharmaceutical Holdings Ltd. | 30 Jun 2024 | 325,855,528 (57.15%) |
| Beijing Yuanfeng Private Equity Fund Management Partnership (L.P.) | 30 Jun 2024 | 3,607,938 (0.63%) |
| First Seafront Fund Management Co., Ltd. | 30 Jun 2024 | 2,549,078 (0.45%) |
| China Universal Asset Management Co., Ltd. | 30 Jun 2024 | 2,025,715 (0.36%) |
| Hasil Dividen (DY TTM) | 50.00% |
| Nisbah Pembayaran | 44.23% |
| Jangkaan Pembayaran Dividen Seterusnya | Feb 2027 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 30 Jan 2026 | 23 Jan 2026 | 12 Feb 2026 | CNY 2.45 Tunai |
| 02 Jul 2024 | 25 Jun 2024 | 12 Jul 2024 | CNY 1.28 Tunai |
| 26 May 2023 | 19 May 2023 | 06 Jun 2023 | CNY 1.12 Tunai |
| 24 May 2022 | 17 May 2022 | 02 Jun 2022 | CNY 0.5 Tunai |
| 15 Jun 2021 | 08 Jun 2021 | 24 Jun 2021 | CNY 0.3 Tunai |
| 15 Jun 2020 | 08 Jun 2020 | 24 Jun 2020 | CNY 0.3 Tunai |
| 01 Jul 2019 | 24 Jun 2019 | 15 Jul 2019 | CNY 0.22 Tunai |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |